News

Osi Pharmaceuticals, a biotechnology company, and Genentech, have announced that Osi has submitted a supplemental new drug application to the FDA for the use of Tarceva as a

Financial Highlights: Increased sales of $1.0 million in our infectious disease product lines were partially offset by a decrease of $0.5 million in sales of Eclectica” as a

Ferring Pharmaceuticals, a specialty biopharmaceutical company, has launched Firmagon, a new treatment option in hormonal therapy for prostate cancer, in Europe. The European launch of Firmagon follows the

Takeda Pharmaceutical Company has filed a new drug application to the Ministry of Health, Labour and Welfare for Lampion for treatment of secondary eradication of Helicobacter pylori. According

Under the agreement, American CareSource will make available its full complement of ancillary care services to InterGroup’s clients through a network of ancillary care providers. American CareSource expects

For the fiscal year 2008, the company reported a net loss of E21.28 million or E0.58 per share, a decrease of 71%, compared to a net loss of

Bristol-Myers Squibb Canada, a pharmaceutical and related healthcare products company, has announced that it will relocate headquarters to Technoparc Montreal, effective March 23, 2009. The relocation of some

Boston Scientific will use the new license in ultra-low power integrated circuits for implantable cardiac rhythm management device applications. Sean Redmond, vice president of worldwide field operations at

According to ReGear, the funds will be used to drive growth and further expansion into the global sports medicine, physical medicine, rehabilitation, and chiropractic markets, and develop products